Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What is the long-term efficacy of percutaneous ethanol injection for small hepatocellular carcinoma?

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 78–79 (2006)Cite this article

boxed-textEbara M et al. (2005) Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 43: 458–464

Patients who are at risk for hepatocellular carcinoma should be routinely screened, so that cancer can be detected at an early stage and curative therapy is possible

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ebara M et al. (1990) Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: Study of 95 patients. J Gastroenterol Hepatol 5: 616–626

    Article  CAS  Google Scholar 

  2. Livraghi T et al. (1992) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 69: 925–929

    Article  CAS  Google Scholar 

  3. Bruix J et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421–430

    Article  CAS  Google Scholar 

  4. Bhartia B et al. (2003) Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 180: 577–584

    Article  Google Scholar 

  5. Valls C et al. (2004) Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol 182: 1011–1017

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor of Medicine at the University of Toronto and University Health Network, Toronto, ON, Canada

    Morris Sherman

Authors
  1. Morris Sherman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Morris Sherman.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sherman, M. What is the long-term efficacy of percutaneous ethanol injection for small hepatocellular carcinoma?. Nat Rev Gastroenterol Hepatol 3, 78–79 (2006). https://doi.org/10.1038/ncpgasthep0408

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0408

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing